On Oct. 8, 2009, Omeros Corp. launched an initial public offering at $10.00 per share and raised $62.1 million in net proceeds. The company had 62 employees as of Dec. 31, 2008.

Omeros Corp. was founded in Seattle in 1994 as a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.